FUCHS HENRY J 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Sep 17, 2024
Insider Transaction Report
Form 4
FUCHS HENRY J
Chief Medical Officer
Transactions
- Award
Common Stock
2024-04-30$68.65/sh+300$20,594→ 197,172 total - Tax Payment
Common Stock
2024-09-13$84.90/sh−12,098$1,027,120→ 185,074 total
Footnotes (1)
- [F1]Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan.